YAP1 and cancer: Additionally, Ma et al. (2024) found that ENO1 confers GEM resistance in pancreatic cancer through the Hippo signaling pathway by elevating YAP1 expression, suggesting that the moonlighting function of ENO1 similarly influences cancer chemoresistance.